First Time Loading...

Dexcom Inc
NASDAQ:DXCM

Watchlist Manager
Dexcom Inc Logo
Dexcom Inc
NASDAQ:DXCM
Watchlist
Price: 124.34 USD -9.91% Market Closed
Updated: Apr 27, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

6.3B
-5%
Assets
Growth Rates:
1 Year
+16%
3 Years
+46%
5 Years
+227%
7 Years
+1 455%
10 Years
+5 014%
4.2B
-3%
Liabilities
Growth Rates:
1 Year
+29%
3 Years
+70%
5 Years
+235%
7 Years
+3 426%
10 Years
+10 827%
2.1B
-9%
Equity
Growth Rates:
1 Year
-3%
3 Years
+13%
5 Years
+212%
7 Years
+629%
10 Years
+2 360%

Balance Sheet Decomposition
Dexcom Inc

6.3B
Assets
4.2B
Liabilities
6.3B
Assets
4.2B
Liabilities
Current Assets 4.4B
Cash & Short-Term Investments 2.7B
Receivables 987.5m
Other Current Assets 714.3m
Non-Current Assets 1.8B
PP&E 1.2B
Intangibles 159.7m
Other Non-Current Assets 494.4m
Current Liabilities 1.6B
Accounts Payable 276.4m
Accrued Liabilities 1.3B
Other Current Liabilities 25.9m
Non-Current Liabilities 2.6B
Long-Term Debt 2.5B
Other Non-Current Liabilities 147.1m

Balance Sheet
Dexcom Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
72
86
95
442
1 137
446
818
1 053
642
566
Cash Equivalents
72
86
95
442
1 137
446
818
1 053
642
566
Short-Term Investments
12
29
29
107
249
1 087
1 890
1 679
1 814
2 158
Total Receivables
42
74
102
134
227
286
429
514
713
988
Accounts Receivables
42
74
102
134
227
286
429
514
713
974
Other Receivables
0
0
0
0
0
0
0
0
0
14
Inventory
16
35
45
45
71
120
235
357
307
560
Other Current Assets
4
7
9
17
17
30
54
82
193
155
Total Current Assets
146
231
280
745
1 700
1 969
3 425
3 684
3 669
4 426
PP&E Net
31
55
109
146
183
393
609
890
1 136
1 185
PP&E Gross
31
55
109
146
183
393
609
890
1 136
1 185
Accumulated Depreciation
33
38
47
55
80
105
154
232
363
509
Intangible Assets
3
2
0
0
0
0
0
32
173
135
Goodwill
3
4
11
12
19
19
19
27
26
25
Other Long-Term Assets
2
0
2
2
15
14
238
301
388
494
Other Assets
3
4
11
12
19
19
19
27
26
25
Total Assets
185
N/A
292
+58%
403
+38%
904
+124%
1 916
+112%
2 395
+25%
4 291
+79%
4 933
+15%
5 392
+9%
6 265
+16%
Liabilities
Accounts Payable
10
19
25
47
76
102
163
189
238
276
Accrued Liabilities
28
45
77
89
144
256
440
514
815
1 249
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
2
2
0
0
0
1
9
0
777
5
Other Current Liabilities
1
1
1
3
3
2
2
17
10
26
Total Current Liabilities
41
67
102
139
222
360
614
721
1 839
1 556
Long-Term Debt
2
0
6
334
1 018
1 074
1 721
2 039
1 257
2 493
Deferred Income Tax
0
0
0
0
0
0
0
6
5
0
Other Liabilities
2
4
11
12
13
78
129
126
158
147
Total Liabilities
44
N/A
71
+59%
119
+68%
485
+307%
1 253
+158%
1 512
+21%
2 464
+63%
2 891
+17%
3 260
+13%
4 196
+29%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
498
555
621
672
799
696
202
139
480
1 021
Additional Paid In Capital
638
777
906
1 094
1 561
1 676
2 125
2 109
2 258
3 515
Treasury Stock
0
0
0
0
100
100
100
206
595
2 451
Other Equity
0
0
1
3
2
2
3
1
12
17
Total Equity
140
N/A
221
+58%
284
+28%
419
+48%
663
+58%
883
+33%
1 827
+107%
2 042
+12%
2 132
+4%
2 069
-3%
Total Liabilities & Equity
185
N/A
292
+58%
403
+38%
904
+124%
1 916
+112%
2 395
+25%
4 291
+79%
4 933
+15%
5 392
+9%
6 265
+16%
Shares Outstanding
Common Shares Outstanding
309
327
338
348
360
366
384
388
386
385

See Also

Summary
DXCM intrinsic value, competitors valuation, and company profile.
DCF Valuation
DXCM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
DXCM stock valuation using valuation multiples.
Wall Street Estimates
DXCM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
DXCM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 131,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.